Knockdown of PTPRN2 or PLCβ1 in four other breast cancer cell lines (BT‐549, CNLM1a, HCC‐1806, and MDA‐MB‐468) also significantly reduced the migratory capacity of these cells (Appendix Fig S2E–L). Here, PTPRN2 is linked to breast cancer.